These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30720338)

  • 21. Health professionals' views about who would benefit from using a closed-loop system: a qualitative study.
    Lawton J; Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Randell T; Besser REJ; Trevelyan N; Hovorka R;
    Diabet Med; 2020 Jun; 37(6):1030-1037. PubMed ID: 31989684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences in Sensor-Augmented Pump Therapy in Families with two Children with Type 1 diabetes: A Qualitative Study.
    Bomba F; Müller-Godeffroy E; von Sengbusch S
    Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):162-167. PubMed ID: 28750428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
    Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
    Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes.
    Hng TM; Burren D
    Intern Med J; 2018 Nov; 48(11):1400-1404. PubMed ID: 30387315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery.
    Dovc K; Boughton C; Tauschmann M; Thabit H; Bally L; Allen JM; Acerini CL; Arnolds S; de Beaufort C; Bergenstal RM; Campbell F; Criego A; Dunger DB; Elleri D; Evans ML; Fröhlich-Reiterer E; Hofer S; Kapellen T; Leelarathna L; Pieber TR; Rami-Merhar B; Shah VN; Sibayan J; Wilinska ME; Hovorka R;
    Diabetes Care; 2019 Jul; 42(7):1344-1347. PubMed ID: 31221700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
    Alsaleh FM; Smith FJ; Taylor KM
    J Clin Pharm Ther; 2012 Apr; 37(2):140-7. PubMed ID: 21729118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes.
    Farrington C; Stewart ZA; Barnard K; Hovorka R; Murphy HR
    Diabet Med; 2017 Oct; 34(10):1461-1469. PubMed ID: 28631849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
    Messer LH; Forlenza GP; Sherr JL; Wadwa RP; Buckingham BA; Weinzimer SA; Maahs DM; Slover RH
    Diabetes Care; 2018 Apr; 41(4):789-796. PubMed ID: 29444895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
    Adams RN; Tanenbaum ML; Hanes SJ; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    Diabetes Technol Ther; 2018 Oct; 20(10):648-653. PubMed ID: 30239219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Patient Experience of Long-Term Hybrid Closed-Loop Insulin Pump Use.
    Wang LR; Malcolm J; Arnaout A; Humphrey-Murto S; LaDonna KA
    Can J Diabetes; 2021 Dec; 45(8):750-756.e3. PubMed ID: 33958309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescents' and their parents' experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study.
    Rankin D; Kimbell B; Hovorka R; Lawton J
    Chronic Illn; 2022 Dec; 18(4):742-756. PubMed ID: 33472409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes.
    Ruan Y; Thabit H; Leelarathna L; Hartnell S; Willinska ME; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Evans ML; Pieber TR; Arnolds S; Hovorka R;
    Diabetes Care; 2016 May; 39(5):830-2. PubMed ID: 26965717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A qualitative study of clinician attitudes towards closed-loop systems in mainstream diabetes care in England.
    Farrington C; Murphy HR; Hovorka R
    Diabet Med; 2020 Jun; 37(6):1023-1029. PubMed ID: 31943318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient Perception and Satisfaction With Insulin Pump System: Pilot User Experience Survey.
    Grando MA; Bayuk M; Karway G; Corrette K; Groat D; Cook CB; Thompson B
    J Diabetes Sci Technol; 2019 Nov; 13(6):1142-1148. PubMed ID: 31055947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.
    Lal RA; Ekhlaspour L; Hood K; Buckingham B
    Endocr Rev; 2019 Dec; 40(6):1521-1546. PubMed ID: 31276160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
    Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
    Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.